Syed Azharuddin

Syed Azharuddin practices at WVU Medicine Uniontown Hospital in Uniontown, Pennsylvania, part of West Virginia University Health System.

Syed Azharuddin's NPI, 1225489727, was assigned on June 27, 2016. Syed Azharuddin holds Pennsylvania license MT220156.

Syed Azharuddin's primary practice is WVU Medicine Uniontown Hospital, at 500 West Berkeley Street, Uniontown, PA 15401 in Fayette County. The practice phone is (724) 430-5000.

Syed Azharuddin's primary practice is WVU Medicine Uniontown Hospital in Uniontown, Pennsylvania, part of West Virginia University Health System. Syed Azharuddin is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is Garrett Medical Group. Dmand AI also links Syed Azharuddin to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Syed Azharuddin practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Syed Azharuddin's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dmand AI has Syed Azharuddin's licenses on file in 2 states: Pennsylvania and Illinois.

CMS data shows 566 Medicare services from Syed Azharuddin across 12 procedure codes in 2024, for 227 Medicare patients. Medicare paid $43,495 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 227 Medicare patients who saw Syed Azharuddin in 2024. The largest group is 65 to 74, with 100 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Syed Azharuddin's median patient age at 67, with 48% women.

In 2024, Syed Azharuddin wrote 339 Medicare Part D claims for 84 patients. 56% of them were for generic drugs. CMS names the drug for 201 of them, across 5 drugs with 11 or more claims each, at $51,770 in total drug cost. In 2023, CMS named 52 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Syed Azharuddin for performance year 2024, reported through an alternative payment model (APM). Syed Azharuddin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Syed Azharuddin in 2020. The most frequent topics are Emergencies and Intensive Care Units. Syed Azharuddin has published most often in Crit Care Nurs Q. Syed Azharuddin's most frequent co-authors are Hammad Arshad, MD, Thomas D. Bauman, MD and Tariq Javed Cheema, MD.

CMS Open Payments shows 15 general payments to Syed Azharuddin from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $265.